In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how the disease transforms into its most lethal form and identified a promising new treatment strategy.
Jul 25, 2025
0
126
Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from scientists at Houston Methodist.
Jul 16, 2025
0
17
Semen analysis is traditionally used as part of male fertility assessments, but researchers from the University of Adelaide believe it has the potential to promote healthier lifestyles.
Jul 11, 2025
0
75
A new study by University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.
Jul 9, 2025
0
19
Many medicines begin life with one purpose and end up proving useful for a completely different reason.
Jun 16, 2026
0
4
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing antitumor immunity, according to a preclinical study led by investigators at Weill Cornell ...
Jun 15, 2026
0
11
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve ...
Jun 15, 2026
0
4
The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor, as adjuvant treatment for adult patients with renal cell carcinoma with a clear cell component ...
Jun 15, 2026
0
3
A research team at Kanazawa University, led by Professor Atsushi Mizokami, Associate Professor Koji Izumi and Specially Appointed Assistant Professor Taiki Kamishima (a fourth-year doctoral student at the Graduate School ...
Jun 12, 2026
0
5
A Northwestern Medicine study has offered new clues as to why immunotherapy works well for some bladder cancer patients but fails for others, according to a study published in the Journal of Clinical Investigation.
Jun 10, 2026
0
3
